Revenue
$194.4m
+6.8% ↑ vs $182m
Capex fell 58.4% as the 4G program rolled off, but OCF/EBITDA dropped from 99.2% to 72.5% even as EBITDA grew to $59.6m.
Revenue context before the current result.
EBITDA margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
FY25 vs FY24
Revenue
$194.4m
+6.8% ↑ vs $182m
EBITDA
$0m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net profit after tax
$0m
flat vs $0m
Net cash inflow from operating activities
$43.2m
-18.3% ↓ vs $52.9m
Operating profit
$0m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Profit before tax
$0m
flat vs $0m
Cash and cash equivalents
$0m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Total assets
$460.3m
+6.2% ↑ vs $433.5m
What changed
Capex fell 58.4% to $13.4m (6.9% of revenue, down from 17.7%) as the 4G upgrade program normalised.
On the operating line, revenue rose 6.8% to $194.4m and the group swung to a $1.4m NPAT (FY24: $0.3m loss) and $0.2m PBT (FY24: $7.0m loss). The NPAT line is flattered by a roughly $1.2m net tax credit, so PBT is the cleaner read on operating progress.
Net debt dropped to $11.8m from $22.1m, taking net debt/EBITDA to 0.20x from 0.41x.
What matters
FCF rose $14.7m year-on-year, but capex fell $18.8m while OCF fell $9.7m. The post-4G normalised capex run-rate is the more important number for valuing the business than the FY25 print, and management has not provided an FY26 capex guide in the supplied materials.
Operating cash conversion deteriorated despite EBITDA growth. OCF/EBITDA at 72.5% is roughly 27 percentage points below FY24's 99.2%. Receivable days improved modestly to 47.5 from 50.7, so a debtor build alone does not explain the gap — investors need clarity on which working-capital or non-cash items absorbed cash.
North America segment result fell 19.5% on revenue up 1.5%. The second-largest geography saw segment result drop to $17.7m from $22.0m. New Zealand (+13% revenue, +12.5% result) is carrying group performance and rose to 38.3% of revenue from 35.7%. North America margin trajectory is now the key segment question.
Expectations
Management states it delivered to the top end of, or exceeded, guidance on all key measures, but the specific FY25 guidance bands and any FY26 outlook are not detailed in the supplied excerpts.
HY25 revenue of $95.9m represented 49.3% of the full-year figure, so phasing was broadly even rather than second-half loaded. With the 4G upgrade program rolling off, the absence of an explicit FY26 capex guide is the most material shape variable — any return to elevated capex would unwind much of the FCF improvement that headlined this release.
Quality of result
The capital-structure improvement is genuine and improves financial flexibility regardless of how cash flows trend from here.
Less durable is the FCF print. The 12x year-on-year jump is largely a capex base effect — the $18.8m drop in PP&E investment swamps the $9.7m decline in operating cash flow. Cash conversion of 72.5% versus 99.2% prior implies working-capital or non-cash timing items absorbed cash as EBITDA rose; receivable days fell to 47.5 from 50.7, so debtor movement is not the explanation. NPAT of $1.4m on equity of $331.7m delivers ROE of 0.4%, which means absolute earnings power remains thin relative to the asset base, and that NPAT was supported by a tax credit. The headline FCF figure is best treated as a transition-year outcome rather than a steady-state run rate.
Unresolved
This briefing cannot assess whether the FY25 cash-conversion fall reflects a one-period working-capital or timing effect or a structural change in how revenue translates into operating cash flow.
Chat
Ask follow-up questions about EROAD's FY25 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
EROAD FY25 Annual Report
FY25 / financial reportEROAD FY25 Investor Presentation
FY25 / results presentationEROAD FY25 Market Release
FY25 / results releaseEROAD FY25 Results Announcement
FY25 / results announcementEROAD FY24 Annual Report
FY24 / financial reportEROAD FY24 Market Release
FY24 / results releaseEROAD FY24 Results Announcement
FY24 / results announcementEROAD H1 FY25 Interim Report
HY25 / financial reportEROAD H1 FY25 Market Release
HY25 / results releaseEROAD H1 FY25 Results Announcement
HY25 / results announcementEROAD H1 FY25 Investor Presentation
FY25 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Cash conversion quality
This result converted 72.5% of EBITDA to operating cash flow, -26.8pp versus the prior comparable period.
Earnings quality and statutory distortions
This result includes a statutory earnings-quality distortion flag.
Leverage and balance-sheet risk
Net debt / EBITDA is 0.20x, -0.22x versus the prior comparable period.
Revenue growth context
Revenue growth was 6.8% for this reporting period.
Get the next EROAD briefing and related NZX reporting-season updates by email.